CEConversations
By Creative Educational Concepts
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Creative Educational Concepts
Category: Science
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 1
Reviews: 0
Episodes: 47
Description
Welcome to CEConversations, a clinical podcast presented by Creative Educational Concepts designed to improve clinician performance and optimize patient outcomes.
| Episode | Date |
|---|---|
|
Evolving Paradigms in Immuno-Oncology: Optimizing Patient Care Through Innovative Delivery Approaches of Immune Checkpoint Inhibitors
|
Jul 01, 2026 |
|
Targeting the Pathway: Evolving Roles of MEK Inhibitors in NF1-Associated PN
|
Jul 01, 2026 |
|
Exploring the Horizons in Advanced or Recurrent Endometrial Cancer: Practical Considerations and Future Directions for New Treatment Strategies
|
Jul 01, 2026 |
|
A CaseWise™ Webcast: From Research to Real-World: ADCs, IO Combinations, and Sequencing in Metastatic NSCLC
|
Jul 01, 2026 |
|
The New Era of Hemophilia Treatment
|
Jan 28, 2026 |
|
MEK Inhibitors in Neurofibromatosis Type 1: Nursing Contributions to NF1-PN Management
|
Oct 01, 2025 |
|
The MEKtrix: Decoding the Real-World Impact of Therapeutic Advances in Neurofibromatosis Type 1–Associated Plexiform Neurofibroma Management Across Pediatric and Adult Populations
|
Sep 19, 2025 |
|
Desmoid Tumors in Focus: Early Recognition, Evolving Therapies, and Nursing-Led Care Strategies
|
Sep 19, 2025 |
|
Emergency Care of Patients with Cancer Receiving CAR T-cell and Bispecific Antibody Immunotherapies Experiencing Serious Adverse Events
|
Aug 28, 2025 |
|
Treating Metastatic HER2-negative Breast Cancer: Oncology Nursing Approaches to Improve Patient Quality of Life
|
Jul 10, 2025 |
|
Advancing Cervical Cancer Care: Navigating New Therapies, Guidelines, and Patient-Centric Approaches
|
Jul 02, 2025 |
|
MEK Inhibitors in Neurofibromatosis Type 1: Latest Advances and Real-World Applications in NF1-PN Management
|
Jun 19, 2025 |
|
All Hands on Deck: Spotlight on Clinical Advances in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
|
Mar 10, 2025 |
|
Advancements in the Management of Relapsed/Refractory B-Cell Malignancies – Integrating Recent Data into Practice to Improve Outcomes
|
Feb 26, 2025 |
|
All Hands on Deck: A Focus on Current and Emerging Treatment Options in the Frontline Setting for Peripheral T-cell Lymphoma
|
Dec 13, 2024 |
|
All Hands on Deck – Utilizing JAK Inhibitors in Myelofibrosis Care: Evidence, Timing, and Strategic Approaches
|
Oct 07, 2024 |
|
All Hands on Deck in Cervical Cancer Care: Screening, Treatment, and Equity Strategies to Improve Patient Lives
|
Oct 07, 2024 |
|
Tailoring Patient Care Using Novel Agents in Metastatic Urothelial Carcinoma: Strategies for the Interprofessional Team
|
Sep 12, 2024 |
|
Advancements and Applications of Antibody Drug Conjugates in HER2-Negative Breast Cancer
|
Aug 08, 2024 |
|
Transforming Metastatic Breast Cancer Management: Harnessing the Power of Antibody-Drug Conjugate Therapies
|
Aug 02, 2024 |
|
Navigating New Waters for Advanced or Recurrent Endometrial Cancer
|
Jul 25, 2024 |
|
Cancer-Associated VTE: Balancing Risk and Reward with Modern Anticoagulation
|
May 15, 2024 |
|
Actionable Strategies in Community Oncology to Achieve Equity in Triple-Negative Breast Cancer
|
Jan 16, 2024 |
|
Primary Care Perspectives on Obesity: Embracing Novel Agents to Optimize Patient Outcomes
|
Oct 24, 2023 |
|
Meeting Complex Challenges in Proteinuric Glomerular Disease: An Expert Review of Emerging Data and Novel Therapeutics for IgA Nephropathy
|
Apr 10, 2023 |
|
Bridging Chasms in Bladder Cancer Care: An Expert Case-based Review of Treatment Selection and Sequencing in an Era of Therapeutic Novelty
|
Mar 07, 2023 |
|
Nephrology Nursing Insights for Managing Chronic Kidney Disease–associated Pruritus: Embracing Evolving Data and Emerging Agents to Optimize Outcomes
|
Jan 23, 2023 |
|
Navigating Novel Terrain in Anemia of Chronic Kidney Disease: A Patient-centric Review of Disease State, Current Chasms in Care, and the Future Promise of HIF-PH Inhibition
|
Dec 27, 2022 |
|
Nephrology Nurse Viewpoints on In-hospital Hyperkalemia Management: Improving Patient Outcomes in Acute Care Settings with Novel Potassium Binders
|
Dec 14, 2022 |
|
Harnessing the Power of Immunotherapy in HCC and BTC: An Expert Exploration of the Past, Present, and Future of Checkpoint Inhibition
|
Dec 13, 2022 |
|
IV Iron Expert Exchange: Data-driven Debates on the Revolutionary Role of IV Iron in Heart Failure
|
Nov 28, 2022 |
|
Pulmonology Perspectives on Biomarker Testing in NSCLC: Multidisciplinary Management in an Era of Rapid Change
|
Nov 17, 2022 |
|
Optimizing Early Breast Cancer Outcomes in the Community Setting: An Expert Review of Emerging Therapies and Evolving Standards of Care in HR+/HER2- Disease
|
Nov 15, 2022 |
|
Clinical Advances in Ovarian Cancer: Exploring the Expanding Role of PARP Inhibitors in the Treatment Paradigm
|
Oct 26, 2022 |
|
Overcoming Pediatric Iron Deficiency Anemia with IV Iron: Interprofessional Approaches to Integrating New Data, Using Novel Agents, and Optimizing Care
|
Sep 30, 2022 |
|
Optimizing Cancer-related Anemia Outcomes in the Community Setting: Interprofessional Approaches and Evidence-supported Strategies for Improving Care with Intravenous Iron
|
Sep 09, 2022 |
|
New Horizons in Unresectable Stage III NSCLC: A Case-based Exploration of Evolving Data and the Emergence of Immunotherapy
|
Sep 09, 2022 |
|
Breaking the Cycle in Cardiorenal Anemia Syndrome: The Practice-changing Role of IV Iron at the CKD–Heart Failure Interface
|
Aug 16, 2022 |
|
2022 EGFR+ Lung Cancer Rapid Recap: The Evolving State of the Science in EGFR+ NSCLC—A Closer Look at the Paradigm-Shifting Synergy of Safety, Efficacy, and Equitable Access
|
Jun 30, 2022 |
|
Overcoming Disparity with Novelty in Triple-Negative Breast Cancer: Community Oncology Perspectives on Promoting Equity and Improving Clinical Outcomes
|
May 09, 2022 |
|
Advancing Therapeutic Paradigms for Ovarian Cancer in The Era of PARP Inhibitors: A Guide for The Oncology Nurse
|
May 04, 2022 |
|
Targeting Unmet Patient Needs in Diffuse Large B-Cell Lymphoma (DLBCL): Emerging Strategies for the Interprofessional Healthcare Team
|
Apr 26, 2022 |
|
Interprofessional Perspectives on the Evolving Heart Failure Treatment Paradigm: Harnessing Novel Therapeutics to Optimize Outcomes & Overcome Disparities in Care
|
Apr 20, 2022 |
|
Infusing Renewed Hope into Cancer-related Anemia with Intravenous Iron: An Expert-Led Exploration of Recent and Emerging Trial Data and Current Guideline Recommendations
|
Mar 22, 2022 |
|
The Shot Heard 'Round the World: Vaccinating the Pandemic
|
Feb 25, 2021 |
|
Restoring Normalcy via the Power of Immunology: Foundational Principles and Practical Questions
|
Feb 15, 2021 |
|
COVID-19: What We Know About the Virus & the Disease
|
Feb 03, 2021 |